BeOne Medicines AG (BVMF:B1ME34)

BeOne Medicines AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,957	2,627	3,172	3,870	4,376	1,382
Short-Term Investments	-	-	-	665.25	2,245	3,269
Cash & Short-Term Investments	4,091	2,627	3,172	4,535	6,621	4,651
Cash Growth	50.72%	-17.16%	-30.06%	-31.50%	42.36%	373.24%
Accounts Receivable	861.82	676.28	358.03	173.17	483.11	60.4
Other Receivables	9.69	32.83	37.86	25.82	17.06	19.27
Receivables	871.51	709.11	395.89	198.98	500.18	79.67
Inventory	530.93	494.99	416.12	282.35	242.63	89.29
Prepaid Expenses	-	49.37	88.26	83.09	138.81	57.74
Restricted Cash	-	9.31	11.47	0.2	0.33	0.31
Other Current Assets	139.99	101.41	119.88	107.65	111.32	83.01
Total Current Assets	5,633	3,992	4,203	5,207	7,614	4,961
Property, Plant & Equipment	1,622	1,718	1,419	955.91	705.04	448.27
Long-Term Investments	100.49	128.93	89.64	91.78	100.79	49.34
Goodwill	-	-	-	-	0.11	0.11
Other Intangible Assets	173.49	51.1	57.14	40.62	46.68	5
Long-Term Deferred Tax Assets	-	-	-	-	-	65.96
Other Long-Term Assets	35.48	31.56	35.72	83.91	69.03	71.39
Total Assets	7,596	5,921	5,805	6,379	8,536	5,601
Accounts Payable	613.5	405	315.11	294.78	262.4	231.96
Accrued Expenses	229.65	780.48	624.92	480.1	534.33	389.75
Short-Term Debt	767.84	816.95	659.79	314.83	424.74	334.71
Current Portion of Long-Term Debt	209.15	34.58	28.58	14.14	2.82	0.31
Current Portion of Leases	-	17.58	21.95	24.04	21.93	13.9
Current Income Taxes Payable	76.06	25.93	22.95	25.19	21.4	20.38
Current Unearned Revenue	-	-	-	213.86	187.41	-
Other Current Liabilities	453.76	134.39	136.82	101.59	144.53	84.2
Total Current Liabilities	2,350	2,215	1,810	1,469	1,600	1,075
Long-Term Debt	139.7	166.48	197.62	209.15	202.11	183.64
Long-Term Leases	51.39	44.28	22.25	34.52	43.04	29.42
Long-Term Unearned Revenue	29.1	30.32	34.2	80.2	266.64	49.14
Pension & Post-Retirement Benefits	-	16.41	15	7.76	7.81	8.11
Long-Term Deferred Tax Liabilities	39.13	42.01	16.49	16	14.17	10.79
Other Long-Term Liabilities	865.93	74.29	172.27	179.78	269.63	375.22
Total Liabilities	3,475	2,589	2,268	1,996	2,403	1,732
Common Stock	0.14	0.14	0.14	0.14	0.13	0.12
Additional Paid-In Capital	12,552	12,088	11,599	11,541	11,191	7,415
Retained Earnings	-8,643	-8,607	-7,962	-7,080	-5,077	-3,553
Comprehensive Income & Other	210.45	-148.99	-99.45	-77.42	17.95	6.94
Total Common Equity	4,121	3,332	3,537	4,383	6,133	3,869
Shareholders' Equity	4,121	3,332	3,537	4,383	6,133	3,869
Total Liabilities & Equity	7,596	5,921	5,805	6,379	8,536	5,601
Total Debt	1,168	1,080	930.19	596.68	694.64	561.96
Net Cash (Debt)	2,923	1,548	2,242	3,938	5,926	4,089
Net Cash Growth	75.91%	-30.96%	-43.08%	-33.54%	44.94%	479.63%
Net Cash Per Share	26.07	14.70	21.47	38.19	63.87	48.98
Filing Date Shares Outstanding	110.66	106.72	104.58	104.32	102.68	91.6
Total Common Shares Outstanding	110.62	106.72	104.58	104.32	102.68	91.6
Working Capital	3,283	1,777	2,393	3,739	6,014	3,885
Book Value Per Share	37.25	31.22	33.82	42.02	59.73	42.24
Tangible Book Value	3,947	3,281	3,480	4,343	6,086	3,864
Tangible Book Value Per Share	35.68	30.75	33.28	41.63	59.27	42.18
Land	-	65.49	65.49	65.49	65.49	-
Buildings	-	607.86	231.66	222.45	144.08	111.53
Machinery	-	485.14	392.21	334.59	237.79	175.31
Construction In Progress	-	654.02	740.62	293.63	186.84	85.78
Leasehold Improvements	-	64.68	60.12	53.79	50.29	37.64

Source: S&P Global Market Intelligence. Standard template. Financial Sources.